Search results for "Platelet-derived growth factor receptor"

showing 7 items of 37 documents

Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis

2010

A genetic basis of hepatocellular carcinoma (HCC) has been well-established and major signaling pathways, such as p53, Wnt-signaling, transforming growth factor-β (TGF-β) and Ras pathways, have been identified to be essential to HCC development. Lately, the family of platelet-derived growth factors (PDGFs) has shifted to the center of interest. We have reported on spontaneously developing liver fibrosis in PDGF-B transgenic mice. Since HCC rarely occurs in healthy liver, but dramatically increases at the cirrhosis stage of which liver fibrosis is a preliminary stage, we investigated liver cancer development in chemically induced liver carcinogenesis in these mice. HCC induction was performe…

Vascular Endothelial Growth Factor AAlkylating AgentsCancer Researchmedicine.medical_specialtyCarcinoma HepatocellularCirrhosisPlatelet-derived growth factorBlotting WesternMice TransgenicBiologymedicine.disease_causeImmunoenzyme TechniquesMicechemistry.chemical_compoundLiver Neoplasms ExperimentalInternal medicinemedicineAnimalsHumansDiethylnitrosamineRNA MessengerReverse Transcriptase Polymerase Chain ReactionCancerProto-Oncogene Proteins c-sismedicine.diseaseFibroblast Growth FactorsPlatelet Endothelial Cell Adhesion Molecule-1Vascular endothelial growth factorEndocrinologyOncologychemistryPhenobarbitalbiology.proteinAnticonvulsantsCarcinogenesisLiver cancerPlatelet-derived growth factor receptorTransforming growth factorInternational Journal of Cancer
researchProduct

Priming with a Combination of Proangiogenic Growth Factors Enhances Wound Healing in Streptozotocin-Induced Diabetes in Mice

2010

<i>Background:</i> Numerous proangiogenic growth factors have been shown to improve impaired wound healing. This study evaluated the effects of subcutaneous pretreatment with a combination of proangiogenic growth factors on wound closure, mechanical properties, vessel density, and morphology. <i>Methods:</i> Thirty-six Balb/c mice with streptozotocin-induced diabetes were divided into 3 groups. A mixture of VEGF (35.0 µg), bFGF (2.5 µg), and PDGF (3.5 µg) was administered subcutaneously 3, 5, and 7 days prior to wounding in the first group, whereas the second group received three doses of 3.5 µg PDGF. Wound sizes were assessed daily and the repaired tissues were harv…

Vascular Endothelial Growth Factor Amedicine.medical_specialtyVEGF receptorsNeovascularization PhysiologicPriming (immunology)PharmacologyDiabetes Mellitus ExperimentalDiabetes ComplicationsMiceTensile StrengthDiabetes mellitusAnimalsMedicineAngiogenic ProteinsSkinPlatelet-Derived Growth FactorMice Inbred BALB CWound Healingbiologybusiness.industrymedicine.diseaseStreptozotocinSurgeryWound areaDiabetic wound healingbiology.proteinFemaleFibroblast Growth Factor 2SurgeryCollagenSkin TemperaturebusinessWound healingPlatelet-derived growth factor receptormedicine.drugEuropean Surgical Research
researchProduct

Modification of xenogenic bone substitute materials - effects on the early healing cascadein vitro

2013

Introduction Initial platelet activation with subsequent cytokine release at the defect site plays a crucial role in tissue integration. The aim of this study was to evaluate the influence of topographic and biomimetic collagen modifications of a xenogenic bone substitute material (BSM) on in vitro platelet activation and cytokine release. Material and Methods Three types of xenogenic BSM were used. Two BSM with different levels of granularity (large granule BSM [XBSM/L], small granule BSM [XBSM/S]) and a BSM with collagen (XBSM/C). All three samples were incubated with platelet concentrate of four healthy volunteers at room temperature for 15 min. For all groups, highly thrombogenic collag…

Vascular Endothelial Growth Factor Amedicine.medical_specialtymedicine.medical_treatmentEnzyme-Linked Immunosorbent AssayIn Vitro TechniquesBiomimetic MaterialsTransforming Growth Factor betaIn vivoInternal medicinemedicineHumansPlateletPlatelet activationBone regenerationPlatelet-Derived Growth FactorMineralsWound HealingbiologyPlatelet CountChemistryPlatelet ActivationIn vitroInsulin-Like Growth Factor Binding Protein 1CytokineEndocrinologyBone SubstitutesImmunologybiology.proteinCytokinesCollagenOral SurgeryWound healingPlatelet-derived growth factor receptorClinical Oral Implants Research
researchProduct

Early implant healing: promotion of platelet activation and cytokine release by topographical, chemical and biomimetical titanium surface modificatio…

2011

Abstract Objectives: Platelet releasate has been shown to promote osteogenetic cell proliferation and differentiation. Topography and chemistry of biomaterials have high impact on platelet activation. More specifically, the bioactive cell adhesive peptide sequence Arg–Gly–Asp (RGD) triggers platelet activation mediated by the αIIbβ3 integrin receptor. Accordingly, topographical, chemical and biomimetical (immobilized RGD peptide) modifications of titanium (Ti) surfaces may enhance early platelet activation and bony healing of implants. Therefore, the aim of the study was to evaluate platelet activation with subsequent platelet-derived cytokine release by accordingly modified Ti surfaces. Ma…

biologyChemistryGrowth factormedicine.medical_treatmentDegranulationVascular endothelial growth factorchemistry.chemical_compoundCytokineImmunologybiology.proteinmedicineBiophysicsPlateletPlatelet activationOral SurgeryReceptorPlatelet-derived growth factor receptorClinical Oral Implants Research
researchProduct

Influence of Vascular Load on Plasma Endothelin-1, Cytokines and Catecholamine Levels in Essential Hypertensives

1998

In vitro studies demonstrated a relationship between ET-1 and basic Fibroblast Growth Factor (bFGF), and of bFGF with Platelet Derived Growth Factor (PDGF). The present study was carried out to investigate in vivo the behaviour after vascular stress of circulating ET-1, bFGF and PDGF, and catecholamines, and their relationship. In 12 healthy normotensives (NTs) and 15 essential hypertensives (Ehs) venous blood samples to determine circulating ET-1, bFGF and PDGF, and catecholamine (EPI and NE) levels were drawn before and at the third minute of a handgrip test. Blood pressures (BP) and heart rate were automatically recorded before starting, and at 1, 2, and 3 minutes during the test. The NT…

medicine.medical_specialtyPlatelet-derived growth factorBasic fibroblast growth factorMuscle Smooth Vascularchemistry.chemical_compoundCatecholaminesStress PhysiologicalInternal medicineBlood plasmaHeart rateInternal MedicinemedicineHumansPlatelet-Derived Growth FactorEndothelin-1Hand Strengthbiologybusiness.industryHypertrophyGeneral MedicineVenous bloodEndothelin 1EndocrinologychemistryVasoconstrictionHypertensioncardiovascular systembiology.proteinCatecholamineFibroblast Growth Factor 2Endothelium VascularCardiology and Cardiovascular MedicinebusinessPlatelet-derived growth factor receptorMuscle Contractionmedicine.drugBlood Pressure
researchProduct

Role of insulin-like growth factors in autocrine growth of human retinoblastoma Y79 cells.

1996

In this study, we have demonstrated that human retinoblastoma Y79 cells produce insulin-like growth factors (IGFs) type I and type II and release them into the medium. We have also ascertained, by means of competitive studies and cross-linking procedure, that Y79 cells contain the type-I IGF receptor (IGF-IR). Furthermore, surface-bound IGF-I is internalised by the receptor, then degraded to amino acids. Insulin, IGF-I and IGF-II caused down-regulation of IGF-IR; the effect is concentration and time dependant. Scatchard analysis demonstrated that incubation with insulin markedly decreased the binding capacity measured for IGF-I while the apparent Kd value calculated for IGF-I binding was no…

medicine.medical_specialtymedicine.medical_treatmentBiologyBiochemistryBinding CompetitiveReceptor IGF Type 1chemistry.chemical_compoundInsulin-Like Growth Factor IIInternal medicineInsulin receptor substratemedicineHumansInsulinInsulin-Like Growth Factor IAutocrine signallingPhosphotyrosineInsulin-like growth factor 1 receptorInsulinRetinoblastomaTyrosine phosphorylationPhosphoproteinsIRS2Insulin receptorautocrine growthEndocrinologychemistrybiology.proteinInsulin Receptor Substrate ProteinsPlatelet-derived growth factor receptorCell DivisionSignal TransductionEuropean journal of biochemistry
researchProduct

2016

Background Contractile myofibroblasts (MFs) accumulate in the joint capsules of patients suffering from posttraumatic joint stiffness. MF activation is controlled by a complex local network of growth factors and cytokines, ending in the increased production of extracellular matrix components followed by soft tissue contracture. Despite the tremendous growth of knowledge in this field, inconsistencies remain in practice and prevention.

musculoskeletal diseases0301 basic medicinePathologymedicine.medical_specialtyPlatelet-derived growth factormacromolecular substancesBiologyExtracellular matrix03 medical and health scienceschemistry.chemical_compound0302 clinical medicineJoint capsulemedicine030222 orthopedicsMultidisciplinaryCell biology030104 developmental biologymedicine.anatomical_structurechemistrybiology.proteinContracturemedicine.symptomSignal transductionMyofibroblastPlatelet-derived growth factor receptorTransforming growth factorPLOS ONE
researchProduct